Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 6/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.45 |
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.45 |
| ▸ | NMUR1 | Q9HB89 | 5/20 | 0.45 |
| ▸ | TFPI | P10646 | 3/20 | 0.43 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.42 |
| ▸ | CTSD | P07339 | 1/20 | 0.42 |
| ▸ | CTSE | P14091 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31437173 | 0.96 | EPHA2 (0.47) | OPRM1OPRK1NMUR2NMUR1TFPI | |
| SCHEMBL31437206 | 0.96 | EPHA2 (0.47) | OPRM1OPRK1NMUR2NMUR1TFPI | |
| SCHEMBL31437184 | 0.95 | NMUR2 (0.45) | OPRM1OPRK1NMUR2NMUR1TFPI | |
| SCHEMBL31437208 | 0.89 | PRCP (0.45) | OPRM1OPRK1EPHA2 | |
| SCHEMBL31467760 | 0.85 | PRCP (0.45) | OPRM1OPRK1NMUR2NMUR1EPHA2 | |
| SCHEMBL31437163 | 0.84 | PRCP (0.44) | NMUR2NMUR1EPHA2 | |
| SCHEMBL31437156 | 0.83 | PTPN1 (0.43) | NMUR2NMUR1EPHA2 | |
| SCHEMBL31437193 | 0.83 | PRCP (0.51) | — | |
| SCHEMBL31437168 | 0.82 | RAMP3 (0.47) | OPRM1OPRK1NMUR2NMUR1 | |
| SCHEMBL31437197 | 0.81 | PRCP (0.47) | OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |